SCHEMBL291625

SCHEMBL291625

O=C1CC=CN=C1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4641826 0.70
SCHEMBL4630012 0.70
SCHEMBL5252500 0.67
Bromide SCHEMBL11114085 0.67
SCHEMBL8700694 0.65
SCHEMBL1685040 0.65
SCHEMBL16828929 0.65
SCHEMBL1787667 0.65
SCHEMBL4767353 0.64
SCHEMBL8898205 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023042178-A2 COMBINATION THERAPY FOR NEURODEGENERATIVE DISEASES ALETA NEUROSCIENCE, LLC (US) 2023-03-23 WO claimed
US-9144633-B2 Implantable devices coated with insulin-mimetic vanadium compounds and methods thereof RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2015-09-29 US claimed
US-20140044768-A1 IMPLANTABLE DEVICES COATED WITH INSULIN-MIMETIC AGENT COMPOSITES AND METHODS THEREOF UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2014-02-13 US claimed
US-5888993-A THERAPY FOR HYPERTENSION, DIABETES, OBESITY THE UNIVERSITY OF BRITISH COLUMBIA 1999-03-30 US claimed
US-5866563-A THERAPY OF HYPERTENSION, OBESITY AND DIABETES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 1999-02-02 US claimed
EP-0606318-B1 VANADIUM COMPOSITIONS UNIV BRITISH COLUMBIA (CA) 1998-01-28 EP claimed
EP-0811380-A2 Use of vanadiumcompositions for lowering blood sugar levels THE UNIVERSITY OF BRITISH COLUMBIA (CA) 1997-12-10 EP claimed
US-5565491-A FOR TREATMENT OF DISEASES MARKED BY MALIGNANT PROLIFERATION OF B CELLS, SUCH AS LEUKEMIA AND LYMPHOMAS; ANTICARCINOGENIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-15 US claimed
EP-0606318-A1 VANADIUM COMPOSITIONS THE UNIVERSITY OF BRITISH COLUMBIA (CA) 1994-07-20 EP claimed
WO-1993006811-A2 VANADIUM COMPOSITIONS COCKBAIN, JULIAN, RODERICK, MICHAELSON (GB) 1993-04-15 WO claimed
WO-2024152013-A1 COMPOSITIONS COMPRISING LIGHT-HARVESTING MOLECULES AND METHODS OF USE THEREOF FOR DETECTING RARE EARTH AND ACTINIDE ELEMENTS LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) 2024-07-18 WO disclosed
US-20240066057-A1 METHOD FOR TREATING PAIN USING VANADIUM COMPOUNDS SHENZHEN FANGSHENGTAI MEDICAL TECHNOLOGY CO., LTD. (CN) 2024-02-29 US disclosed
EP-4252758-A1 METHOD FOR TREATING PAIN BY VANADIUM COMPOUND Shenzhen Fangshengtai Medical Technology Co., Ltd. (CN) 2023-10-04 EP disclosed
US-11746111-B2 Siderophore conjugated pyrazolidinones, and analogues thereof YALE UNIVERSITY (US) 2023-09-05 US disclosed
CN-116082237-A Nitrogen-containing heterocyclic compound and preparation method thereof 安徽中医药大学 2023-05-09 CN disclosed
EP-0316778-A2 2-Hydroxy-pyridone azo compounds, process for their preparation and their use as dyestuffs HOECHST AKTIENGESELLSCHAFT (DE) 1989-05-24 EP disclosed
EP-0316778-A2 2-Hydroxy-pyridone azo compounds, process for their preparation and their use as dyestuffs HOECHST AKTIENGESELLSCHAFT (DE) 1989-05-24 EP disclosed
EP-0316779-A2 Pyridone azo compounds, process for their preparation and their use as dyestuffs HOECHST AKTIENGESELLSCHAFT (DE) 1989-05-24 EP disclosed
US-4104270-A Process for the manufacture of aromatic phosphonates IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1978-08-01 US disclosed
US-3979378-A Water-soluble azo dyes having a substituted 2-hydroxypyridone (6) coupling component BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) 1976-09-07 US disclosed